Avian influenza virus H5N1 induces rapid interferon-beta production but shows more potent inhibition to retinoic acid-inducible gene I expression than H1N1 in vitro
© Mi et al.; licensee BioMed Central Ltd. 2012
Received: 5 January 2012
Accepted: 30 July 2012
Published: 3 August 2012
The mechanisms through which the avian influenza virus H5N1 modulate the host’s innate immune defense during invasion, remains incompletely understood. RIG-I as a pattern recognition receptor plays an important role in mediating innate immune response induced by influenza virus. So, modulating RIG-I might be adopted as a strategy by influenza virus to antagonize the host’s innate immune defense.
Here we chose an avian influenza virus A/tree sparrow/Henan/1/04 (H5N1) directly isolated from a free-living tree sparrow in Mainland China which is amplified in egg allantoic cavity, and researched its interferon induction and manipulation of RIG-I expression compared with influenza virus A/WSN/1933(H1N1), a well characterized mouse adapted strain, in human lung epithelial A549 cells and human embryonic kidney 293T cells.
Although the avian influenza virus H5N1 infection initiated a rapid IFN-beta production early on, it eventually presented a more potent inhibition to IFN-beta production than H1N1. Correspondingly, the H5N1 infection induced low level expression of endogenous RIG-I, an Interferon Stimulating Gene (ISG), and showed more potent inhibition to the expression of endogenous RIG-I triggered by exogenous interferon than H1N1.
Manipulating endogenous RIG-I expression might constitute one of the mechanisms through which avian influenza virus H5N1 control the host’s innate immune response during infection.
KeywordsAvian influenza virus H5N1 Interferon-beta RIG-I
Avian H5N1 influenza viruses were first recognized to be capable of causing human respiratory infection and disease in Hong Kong in 1997 when 18 documented human H5N1 infections with 6 fatalities were identified in conjunction with outbreaks of H5N1 disease among domestic poultry [1–3]. As a result of avian-to-human transmission, 373 laboratory-confirmed human cases (236 deaths) of H5N1 virus infection in 14 countries have been reported to the World Health Organization from 2003 to 18 March 2008 , highlighting the pandemic potential of H5N1 viruses and their growing influence on global public health. Since the 1997 H5N1 avian influenza virus transmission from chicken to human in Hong Kong, cross-species transmissibility of avian influenza virus H5N1 is a major concern in influenza research, but the underlying mechanism(s) of cross-species transmission and the heightened virulence of H5N1 viruses to humans remain largely unknown.
Since first identified in choriontic membranes of embryonated chicken eggs, interferon has been regarded as an important defence line in controlling virus infection [5–7]. In order to successfully invade and amplify, influenza virus has evolved to obtain so many strategies to fight against the above defence system during interplaying with hosts . Retinoic acid-inducible gene-I(RIG-I) as an Pattern Recognition Receptor(PRR) sensing viral cytoplasmic RNA ligand located on the extreme upstream of signalling pathway mediating interferon production . So RIG-I would be controlled or modified to downregulate interferon activation by some viruses such as influenza virus and Hepatitis C Virus , but the mechanisms have not been understood completely.
Considering the important role of innate immune response in controlling virus transmission and pathogenesis [11, 12], in the current study, a novel genotype H5N1 strain A/tree sparrow/Henan/1/04(H5N1) isolated from a tree sparrow in Mainland China was chosen  and its interferon-beta (IFN-β) induction and modulation of endogenous RIG-I expression were compared with human influenza virus H1N1 in human lung epithelial cells. Although the avian influenza virus H5N1 infection caused rapid IFN-β production in early infection, in the late stage of infection, the H5N1 strain showed more potent IFN-β inhibition and induced low level endogenous RIG-I expression than human influenza virus H1N1. Our results further approved that through manipulating innate immune response even the expression of RIG-I, avian influenza virus H5N1 struggle to control the host’s innate immune defense system for facilitating its invasion.
Avian influenza virus A/tree sparrow/Henan/1/04 (H5N1) induces more rapid IFN-β production than human influenza virus H1N1 in early infection
Avian influenza virus H5N1 infection induced low level endogenous RIG-I expression
RIG-I is involved in recognizing H5N1 to produce interferon-beta
The infection of H5N1 exerted potent blockage to endogenous RIG-I expression when treated with exogenous interferon
The critical role of the IFN system in controlling influenza virus transmission was first demonstrated in a classical experiment wherein mice infected with influenza virus and injected with anti-IFN serum were observed to produce higher titers of the virus and an exacerbated pathology . Subsequent studies in knockout mice with defects in their IFN system have confirmed this basic observation . Recent studies in which the IFN-inducing capacity varied in genetically related A-type influenza virus showed that the strain capable of producing the most IFN was attenuated in its pathogenesis in mice [27, 28]. The above researches indicate that IFN plays an important role in limiting human influenza virus or avian influenza virus pathogenesis or transmission.
Since the first reported human case of avian influenza virus H5N1 infection in Hong Kong in 1997 , the avian to human or human to human transmission of H5N1 poses a potential threat to human health. Aquatic birds are considered the natural host of avian influenza virus H5N1 . But recently, some terrestrial birds, such as tree sparrows, have been found carrying H5N1 with no symptoms . This indicates that the host range of avian influenza virus maybe expanding. In addition, some new H5N1 genotypes are emerging through gene reassortment [13, 31]. How those avian influenza viruses pose a threat to humans deserves further study. In the current assay, we chose a new genotype avian influenza virus A/tree sparrow/Henan/1/04(H5N1) isolated from a free-living tree sparrow in Henan Province of Mainland China and studied its modulation of IFN-β and RIG-I in mammalian cells.
In contrast to human influenza virus H1N1, A/tree sparrow/Henan/1/04(H5N1) infection in mammalian cells resulted in rapid IFN-β production during the early stage of infection, but in the late stage, it significantly inhibited the amplification of IFN-β production and showed the same pattern as the Indian isolate of pandemic (H1N1) 2009 influenza virus . Previous studies have demonstrated that highly pathogenic avian influenza virus H5N1 replicated more efficiently than human influenza viruses due to its PA, PB1, and PB2 [33–35]. Our results also proved that A/tree sparrow/Henan/1/04(H5N1) was consistent with other H5N1 strains and that it rapidly and efficiently amplified in mammalian cells, which resulted in the rapid activation of IFN-β signaling in early infection. However, accompanying rapid replication and viral cytoplasmic RNA accumulating, why the rapid IFN-β production was followed with sharp downregulation during H5N1 infection is unknown. In this study, we observed that although A/tree sparrow/Henan/1/04(H5N1) infection caused rapid IFN-β production and STAT-1 phosphorylation during the early stage of infection, it only induced low level endogenous RIG-I expression in comparison to H1N1 in A549 cells. Furthermore, when preinfecting the 293T cells, H5N1 significantly inhibited the endogenous RIG-I expression induced by exogenous interferon than H1N1. Previous investigation showed that low level RIG-I existed in quiescent epithelial cells and ready to sense invading RNA . When the primary interferon produced, it increased RIG-I expression, which again participates in sensing invading RNA and amplifying interferon production. So inhibiting RIG-I expression unavoidly interrupt the above positive feed-back loop. According to these results we assume that manipulating RIG-I expression might be adopted by influenza virus at least as one of strategies antagonizing host’s innate immune response.
Although a latest literature found the polymerase of H5N1 was involved in antagonzing interferon production in chicken macrophage HD-11 cells , the NS1 has been regarded as the key component inhibiting interferon production through targeting many aspects of interferon signalling pathway . In this study NS1 from H5N1 showed more potent inhibition to exogenous interferon than NS1 from H1N1 in the same level of expression. The same level of NS1 from different subtype or strain of influenza virus exhibiting diverse antagonizing capacity might attribute to its property [38, 39]. So, the accumulating NS1 protein during influenza virus infection might be responsible for the differences in inducing interferon or RIG-I expression. Based on these results, during the early stage of infection, H5N1 replicates more efficiently than H1N1 and induced rapid IFN-β production, but in the late stage of infection, it significantly inhibits IFN-β production with NS1 accumulation as showed in influenza C virus NS1 .
Previous studies showed that multistep inhibition contributes to the capacity of NS1 to antagonize the innate immune response of the host, such as through the inhibition to PKR signaling by binding to double strand RNA (dsRNA) [41, 42], inhibition to nuclear export of polyadenylated host mRNA , and inhibition to mRNA splicing and downregulation of IFN production by interacting with CPSF (cleavage and polyadenylation specificity factor) [44–46]. Here we showed that inhibiting endogenous RIG-I expression is another mechanism through which A/tree sparrow/Henan/1/04 (H5N1) antagonizes IFN-β production. This further confirms that the influenza virus inhibits the host innate immune response through multiple steps and aspects.
Virus and cells
A/tree sparrow/Henan/1/04(H5N1) (kindly provided by Professor Li TX, State Key Laboratory of Virology, Wuhan Institute of Virology, Chinese Academy of Sciences) and A/WSN/1933(H1N1) purchased from the American Type Culture Collection (ATCC, Manassas, VA) were propagated in 10-day-old embryonated chicken eggs from specific-pathogen-free flocks (Beijing Merial). Each egg was injected with 0.1 ml of phosphate-buffered saline (PBS) containing ~103 infectious particles, incubated at 35°C with forced air circulation and egg rotation, and maintained at 4°C for 12 h before harvesting. The allantoic fluid was harvested separately from each egg. Those with high hemagglutinin activity were pooled, and aliquots were prepared and stored at −70°C. The hemagglutinin titer of the above subtype of influenza virus was measured with 1% hamster blood cell in a U-shaped plate. Human lung carcinoma cell A549, human embryonic kidney 293T cell (HEK293T) and Madin-Darby Canine Kidney Cell (MDCK) cell were purchased from ATCC and maintained in minimal essential medium (MEM, HyClone). All cell cultures were supplemented with 10% fetal calf serum (PAA Laboratories, Germany), 100 U penicillin, and 100 μg streptomycin per milliliter (Sigma-Aldrich, St. Louis). The cells were incubated at 37°C and 5% carbon dioxide.
Transient transfection of A549 cells with the indicated plasmids was conducted with Lipofectamin 2000 (Invitrogen) according to the manufacturer’s recommendation. Transient transfection of HEK293T cells with indicated plasmids was performed routinely with calcium phosphate method. In each experiment total amounts of DNA in each sample were kept constant by supplementation with the appropriate empty parental expression vector.
Luciferase reporter assay
IFN-luc and ISRE-luc luciferase reporter plasmids were described previously . Briefly, the reporter plasmids were co-transfected with the indicated constructs into A549 cells or HEK293T cells. For normalization of transfection efficiency, Renilla luciferase plasmid was co-transfected as internal control of transfection efficiency. Luciferase activities were measured and normalized as per instructions by the manufacturer (Dual-Luciferase reporter assay system, Promega, WI).
Six-well tissue culture plates were seeded at 1 × 106 MDCK cells per well. At 100% confluence, the cells were washed twice with PBS. Serial dilutions of the virus (10-2 to 10-7) were prepared in MEM containing 20 μg/ml TPCK–trypsin (Sigma-Aldrich). After infection of the wells with 0.5 ml of each dilution, the plates were incubated at 37°C for 1.5 h. The wells were aspirated to remove residual viral solution. Each well was then immediately covered with 2.5 ml MEM containing 0.8% agar and 20 μg/ml TPCK–trypsin. About 5 min later, the agar solidified. The plates were placed in the incubator. After 24 hours, 1.5 ml of 1× neutral red was added per well and incubated for 2 h. Then, the neutral red was pipetted without touching the agar. The quantity of plaque was counted, and the titer of virus was calculated as plaque-forming unit (PFU) per milliliter.
For influenza virus infection, 2 × 106 A549 or 293T cells were seeded in 60 mm-diameter dish. At 24 h post seeding, cells were washed with PBS and infected with influenza viruses (m.o.i = 2) in complete culture medium for 1 h, then virus-containing solutions were removed and cells were continuously cultured in complete culture medium in 5% CO2 incubator at 37°C. For mock infection, the same amount of allantoic fluid from non-inoculated 10-day-old chicken embryos was used to infect the A549 cells.
Quantitative real-time RT-PCR
The complementary DNA (cDNA) number of individual avian influenza virus genes when oligo(dT) is used for reverse transcription can be used to designate the viral infection and amplification in host cells. For cDNA synthesis, total RNA was extracted from the cells infected with the indicated influenza virus using Trizol (Invitrogen, Carlsbad, CA), and reverse transcription was performed with M-MLV reverse transcriptase and oligo(dT)15 (Promega). Single-color real-time PCR System (Bio-Rad, Hercules, CA) was used to detect the levels of influenza virus NP mRNA and IFN-β mRNA. The real-time PCR primers were designed as the following: NP gene, forward primer: 5′-GAC GAA AAG GCA ACG AAC C-3′, reverse primer: 5′-TCA TAC TCC TCT GCA TTG TCT C-3′; human IFN-β gene, forward primer: 5′-AAA CTC ATG AGC AGT CTG CA-3′, reverse primer: 5′-AGG AGA TCT TCA GTT TCG GAG G-3′; human β-actin gene, forward primer: 5′-AGC GAG CAT CCC CCA AAG TT-3′; reverse primer: 5′-AGG GCA CGA AGG CTC ATC ATT-3′.
The cells were lysed in ice-cold lysis buffer containing 50 mM Tris–HCl (pH 7.5), 150 mM NaCl, 1% Nonidet P-40, 0.5% sodium deoxycholate, 0.1% sodium dodecyl sulfate (SDS), and a protease inhibitor cocktail (Sigma-Aldrich). Protein concentrations were determined using the Bradford reagent protocol (Bio-Rad). Equal amounts of proteins were loaded on an SDS-polyacrylamide gel, separated with electrophoresis, and blotted with the indicated antibodies according to the manufacturer's instructions. Immunoreactive proteins were detected with monoclonal antibody against RIG-I (Alme-1; Alexis, Plymouth Meeting, PA), rabbit anti-STAT1, phospho-STAT-1 (Tyr701) (58D6; Cell Signaling Technologies, Beverly, MA), anti-flag M2 monoclonal antibodies (Sigma-Aldrich), anti-NS1 monoclonal antibodies (sc-130568; Santa Cruz Biotechnology), anti-human β-actin monoclonal antibodies (sc-130301; Santa Cruz Biotechnology), and followed by horseradish peroxidase-conjugated secondary antibodies (Cell Signaling Technologies).
This research was supported by a grant from National Natural Science of China (Grant no. 81072350).
MZ carried out the infection, transfection, plaque assay, western blot and luciferase reporter assay, participated in drafting the manuscript. MY carried out the RT-PCR and real-time PCR assay. TY conceived of the study, and participated in its design and coordination and helped to draft the manuscript. All authors read and approved the final manuscript.
- Claas EC, et al.: Human influenza A H5N1 virus related to a highly pathogenic avian influenza virus. Lancet 1998,351(9101):472–477.PubMedView Article
- Subbarao K, et al.: Characterization of an avian influenza A (H5N1) virus isolated from a child with a fatal respiratory illness. Science 1998,279(5349):393–396.PubMedView Article
- Snacken R, et al.: The next influenza pandemic: lessons from Hong Kong, 1997. Emerg Infect Dis 1999,5(2):195–203.PubMedView Article
- World Health Organization avian influenza information. http://www.who.int/csr/disease/avian_influenza/en/.
- Isaacs A, Lindenmann J: Virus interference. I. The interferon. Proc R Soc Lond B Biol Sci 1957,147(927):258–267.PubMedView Article
- Isaacs A, Lindenmann J, Valentine RC: Virus interference. II. Some properties of interferon. Proc R Soc Lond B Biol Sci 1957,147(927):268–273.PubMedView Article
- Lindenmann J, Burke DC, Isaacs A: Studies on the production, mode of action and properties of interferon. Br J Exp Pathol 1957,38(5):551–562.PubMed
- Hale BG, Albrecht RA, Garcia-Sastre A: Innate immune evasion strategies of influenza viruses. Future Microbiol 2010,5(1):23–41.PubMedView Article
- Kato H, Takahasi K, Fujita T: RIG-I-like receptors: cytoplasmic sensors for non-self RNA. Immunol Rev 2011,243(1):91–98.PubMedView Article
- Leung DW, Basler CF, Amarasinghe GK: Molecular mechanisms of viral inhibitors of RIG-I-like receptors. Trends Microbiol 2012,20(3):139–146.PubMedView Article
- Katze MG, He Y, Gale M: Viruses and interferon: a fight for supremacy. Nat Rev Immunol 2002,2(9):675–687.PubMedView Article
- Peiris M: Pathogenesis of avian flu H5N1 and SARS. Novartis Found Symp 2006, 279:56–60.PubMedView Article
- Kou Z, et al.: New genotype of avian influenza H5N1 viruses isolated from tree sparrows in China. J Virol 2005,79(24):15460–15466.PubMedView Article
- Hayman A, et al.: Variation in the ability of human influenza A viruses to induce and inhibit the IFN-beta pathway. Virology 2006,347(1):52–64.PubMedView Article
- Veckman V, et al.: TNF-alpha and IFN-alpha enhance influenza-A-virus-induced chemokine gene expression in human A549 lung epithelial cells. Virology 2006,345(1):96–104.PubMedView Article
- Matikainen S, et al.: Tumor necrosis factor alpha enhances influenza A virus-induced expression of antiviral cytokines by activating RIG-I gene expression. J Virol 2006,80(7):3515–3522.PubMedView Article
- Pichlmair A, et al.: RIG-I-mediated antiviral responses to single-stranded RNA bearing 5'-phosphates. Science 2006,314(5801):997–1001.PubMedView Article
- Ronni T, et al.: Regulation of IFN-alpha/beta, MxA, 2',5'-oligoadenylate synthetase, and HLA gene expression in influenza A-infected human lung epithelial cells. J Immunol 1997,158(5):2363–2374.PubMed
- Saito T, Gale M Jr: Principles of intracellular viral recognition. Curr Opin Immunol 2007,19(1):17–23.PubMedView Article
- Diebold S: Innate recognition of viruses. Immunol Lett 2010,128(1):17–20.PubMedView Article
- Pichlmair A, Reis C: e Sousa. Innate recognition of viruses. Immunity 2007,27(3):370–383.PubMedView Article
- Takeuchi O, Akira S: Recognition of viruses by innate immunity. Immunol Rev 2007, 220:214–224.PubMedView Article
- Yoneyama M, et al.: The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses. Nat Immunol 2004,5(7):730–737.PubMedView Article
- Opitz B, et al.: IFNbeta induction by influenza A virus is mediated by RIG-I which is regulated by the viral NS1 protein. Cell Microbiol 2007,9(4):930–938.PubMedView Article
- Honda K, et al.: Regulation of the type I IFN induction: a current view. Int Immunol 2005,17(11):1367–1378.PubMedView Article
- Koerner I, et al.: Protective role of beta interferon in host defense against influenza A virus. J Virol 2007,81(4):2025–2030.PubMedView Article
- Silverman N, Maniatis T: NF-kappaB signaling pathways in mammalian and insect innate immunity. Genes Dev 2001,15(18):2321–2342.PubMedView Article
- Donelan NR, Basler CF, Garcia-Sastre A: A recombinant influenza A virus expressing an RNA-binding-defective NS1 protein induces high levels of beta interferon and is attenuated in mice. J Virol 2003,77(24):13257–13266.PubMedView Article
- Webster RG, et al.: Evolution and ecology of influenza A viruses. Microbiol Rev 1992,56(1):152–179.PubMed
- Boon AC, et al.: Role of terrestrial wild birds in ecology of influenza A virus (H5N1). Emerg Infect Dis 2007,13(11):1720–1724.PubMedView Article
- Fusaro A, et al.: Gene segment reassortment between Eurasian and American clades of avian influenza virus in Italy. Arch Virol 2010,155(1):77–81.PubMedView Article
- Mukherjee S, et al.: Pandemic (H1N1) 2009 influenza virus induces weaker host immune responses in vitro: a possible mechanism of high transmissibility. Virol J 2011, 8:140.PubMedView Article
- Hatta M, et al.: Growth of H5N1 influenza A viruses in the upper respiratory tracts of mice. PLoS Pathog 2007,3(10):1374–1379.PubMedView Article
- Zeng H, et al.: Highly pathogenic avian influenza H5N1 viruses elicit an attenuated type i interferon response in polarized human bronchial epithelial cells. J Virol 2007,81(22):12439–12449.PubMedView Article
- Dankar SK, et al.: Influenza A virus NS1 gene mutations F103L and M106I increase replication and virulence. Virol J 2011, 8:13.PubMedView Article
- Liniger M, et al.: Highly pathogenic avian influenza virus H5N1 controls type I IFN induction in chicken macrophage HD-11 cells: a polygenic trait that involves NS1 and the polymerase complex. Virol J 2012., 9:
- Hale BG, et al.: The multifunctional NS1 protein of influenza A viruses. J Gen Virol 2008,89(Pt 10):2359–76.PubMedView Article
- Kochs G, et al.: Strong interferon-inducing capacity of a highly virulent variant of influenza A virus strain PR8 with deletions in the NS1 gene. J Gen Virol 2009,90(Pt 12):2990–4.PubMedView Article
- Hale BG, et al.: Inefficient control of host gene expression by the 2009 pandemic H1N1 influenza A virus NS1 protein. J Virol 2010,84(14):6909–22.PubMedView Article
- Pachler K, Vlasak R: Influenza C virus NS1 protein counteracts RIG-I-mediated IFN signalling. Virol J 2011, 8:48.PubMedView Article
- Lu Y, et al.: Binding of the influenza virus NS1 protein to double-stranded RNA inhibits the activation of the protein kinase that phosphorylates the elF-2 translation initiation factor. Virology 1995,214(1):222–8.PubMedView Article
- Tan SL, Katze MG: Biochemical and genetic evidence for complex formation between the influenza A virus NS1 protein and the interferon-induced PKR protein kinase. J Interferon Cytokine Res 1998,18(9):757–66.PubMedView Article
- Chen Z, Li Y, Krug RM: Influenza A virus NS1 protein targets poly(A)-binding protein II of the cellular 3'-end processing machinery. EMBO J 1999,18(8):2273–83.PubMedView Article
- Fortes P, Beloso A, Ortin J: Influenza virus NS1 protein inhibits pre-mRNA splicing and blocks mRNA nucleocytoplasmic transport. EMBO J 1994,13(3):704–12.PubMed
- Lu Y, Qian XY, Krug RM: The influenza virus NS1 protein: a novel inhibitor of pre-mRNA splicing. Genes Dev 1994,8(15):1817–28.PubMedView Article
- Nemeroff ME, et al.: Influenza virus NS1 protein interacts with the cellular 30 kDa subunit of CPSF and inhibits 3'end formation of cellular pre-mRNAs. Mol Cell 1998,1(7):991–1000.PubMedView Article
- Guo B, Cheng G: Modulation of the interferon antiviral response by the TBK1/IKKi adaptor protein TANK. J Biol Chem 2007,282(16):11817–26.PubMedView Article
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.